Health-e Law Podcast, Episode 20 | J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A | Sheppard Mullin Richter & Hampton LLP
What we discussed in this episode:
– How did buzzwords like AI and innovation shape conversations at this year’s J.P. Morgan Healthcare Conference?
– What role does technology play in healthcare transactions?
– How is AI driving the next wave of consolidation among hospitals, health systems and health plans?
– What are the challenges and opportunities in integrating technology platforms during mergers and acquisitions?
– How does technology leadership influence whether an organization becomes a buyer, partner or target, and why is it critical to involve technology leaders early in the deal-making process?
– What is the impact of data assets, analytics platforms and AI-driven tools on healthcare transactions?
– How can organizations balance the cost of technology with their mission to serve patients and communities?
– What legal and regulatory considerations should healthcare organizations prioritize when adopting new technologies?
ABOUT AMANDA ZABLOCKI
Amanda Zablocki is a partner in the Corporate practice group in Sheppard’s New York office and co-leader of the firm’s Healthcare Industry team. A trusted legal and strategic advisor to healthcare organizations nationwide, she helps them to achieve their mission and goals while navigating a dynamic regulatory landscape.
Large-scale, strategic transactions—mergers and acquisitions, joint ventures and strategic partnerships, and corporate reorganizations—are at the center of Amanda’s practice. With extensive industry knowledge, a deep understanding of the key drivers and levers for success, and broad experience navigating the complex healthcare regulatory landscape, she helps clients close high-impact deals that transform healthcare.
Amanda’s clients include health plans and health insurers, hospital systems, academic medical centers, digital health and healthcare technology companies, pharmaceutical and life sciences companies, rare disease organizations, physician practices, management services organizations, value-based care organizations, and 501(c)(3) organizations. Having begun her career in commercial litigation, she brings a litigator’s eye to managing risk in connection with disputes and advocating her clients’ positions.
Amanda co-founded Sheppard’s Women in Healthcare Leadership Collaborative, an exclusive initiative that provides support to women professionals in the healthcare and life sciences industries. She is also co-founder and a board member of Hyper IgM Foundation, an organization committed to improving the treatment, quality of life and long-term outlook for children and adults living with Hyper IgM.
ABOUT MICHAEL ORLANDO
Michael Orlando is a partner in Sheppard’s San Diego (Del Mar) office. He is team leader of the firm’s Technology Transactions team, a member of the Life Sciences, Healthcare and Artificial Intelligence teams, and co-leader of the firm’s Digital Health team. Michael has more than 20 years of experience advising health technology companies, insurers, healthcare systems and providers, academic medical centers and research institutions, medical device manufacturers, and pharmaceutical and wellness companies on intellectual property and business transactions in key strategic areas, including EHR systems procurement and integration, telehealth, wearable devices, remote patient monitoring, mobile health applications, clinical decision support technologies, artificial intelligence, data use, research and collaborations, patent licenses, software licenses, joint ventures, mergers and acquisitions, revenue cycle management, and other outsourcing transactions.
Before entering private practice, Michael founded a software-as-a-service company and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. See less –
link
